Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Tzelepis F, Birdi HK, Jirovec A, Boscardin S, Tanese de Souza C, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo JS.
Tzelepis F, et al. Among authors: parks rj.
Mol Ther Oncolytics. 2020 Oct 14;19:240-252. doi: 10.1016/j.omto.2020.10.007. eCollection 2020 Dec 16.
Mol Ther Oncolytics. 2020.
PMID: 33209979
Free PMC article.